Avance board to meet on May 29 to consider Q4FY26 results
Avance Technologies Limited will hold a board meeting on May 29, 2026, to consider audited financial results for the quarter and year ended March 31, 2026. The board will also review the statutory auditor's report. The trading window for insiders remains closed until 48 hours after the results declaration.

*this image is generated using AI for illustrative purposes only.
Avance Technologies Limited has announced that its board meeting will be held on Friday, May 29, 2026, at the company's registered office. The primary agenda for the meeting is to consider and approve the audited financial results for the quarter and fiscal year ended March 31, 2026, both on a standalone and consolidated basis.
The board will also review the Independent Audit Report to be issued by the statutory auditor, M/s. A. Raghavendra Rao & Associates, Chartered Accountants, for the same period. Any other business matters with the permission of the Chairman may also be transacted during the meeting.
In compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the company's shares has been closed since April 1, 2026. This restriction applies to all Directors, Promoters, Key Managerial Personnel (KMPs), and Designated Persons of the company, as well as their immediate relatives. The window will remain closed until the expiry of 48 hours from the declaration of the financial results.
Key Meeting Details
| Agenda Item | Details |
|---|---|
| Meeting Date | May 29, 2026 |
| Financial Period | Quarter and Year ended March 31, 2026 |
| Results Type | Audited (Standalone & Consolidated) |
| Statutory Auditor | M/s. A. Raghavendra Rao & Associates |
The meeting will be conducted at the registered office located at 404, Corporate Annexe, Sonawala Road, Goregaon (East), Mumbai, Maharashtra. Latesh Poojary, Managing Director, signed the intimation sent to the exchanges.
How have Avance Technologies Limited's revenue and profitability trends evolved over FY2026 compared to the previous fiscal year, and what segments drove growth or decline?
Will the board consider any dividend declaration, share buyback, or capital allocation changes alongside the approval of FY2026 audited results?
Are there any pending regulatory scrutiny or audit qualifications from M/s. A. Raghavendra Rao & Associates that could impact investor confidence in the reported financials?






























